These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18486057)

  • 1. Rifalazil.
    Tuberculosis (Edinb); 2008 Mar; 88(2):148-50. PubMed ID: 18486057
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):151-4. PubMed ID: 18486058
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifabutin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):145-7. PubMed ID: 18486056
    [No Abstract]   [Full Text] [Related]  

  • 4. Cycloserine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):100-1. PubMed ID: 18486041
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of rifalazil in long-term treatment regimens for tuberculosis in mice.
    Shoen CM; Chase SE; DeStefano MS; Harpster TS; Chmielewski AJ; Cynamon MH
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1458-62. PubMed ID: 10817693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifamycin antibiotics and the mechanisms of their failure.
    Adams RA; Leon G; Miller NM; Reyes SP; Thantrong CH; Thokkadam AM; Lemma AS; Sivaloganathan DM; Wan X; Brynildsen MP
    J Antibiot (Tokyo); 2021 Nov; 74(11):786-798. PubMed ID: 34400805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the therapeutic effect of rifamdin on pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Apr; 5(2):74-7. PubMed ID: 6813082
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifalazil and derivative compounds show potent efficacy in a mouse model of H. pylori colonization.
    Rothstein DM; Mullin S; Sirokman K; Söndergaard KL; Johnson S; Gwathmey JK; van Duzer J; Murphy CK
    J Antibiot (Tokyo); 2008 Aug; 61(8):485-8. PubMed ID: 18997386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.
    Rothstein DM; Suchland RJ; Xia M; Murphy CK; Stamm WE
    J Antibiot (Tokyo); 2008 Aug; 61(8):489-95. PubMed ID: 18997387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis.
    Sekaggya-Wiltshire C; Dooley KE
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):615-618. PubMed ID: 31339806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent report of short-term chemotherapy with rifamdin in pulmonary tuberculosis in rural areas].
    Qu SH; Meng ZR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Aug; 7(4):208-9, 253. PubMed ID: 6549552
    [No Abstract]   [Full Text] [Related]  

  • 15. Development potential of rifalazil.
    Rothstein DM; Hartman AD; Cynamon MH; Eisenstein BI
    Expert Opin Investig Drugs; 2003 Feb; 12(2):255-71. PubMed ID: 12556219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis in the aged].
    Aubin L
    Soins Gerontol; 1999; (17):24-5. PubMed ID: 10723444
    [No Abstract]   [Full Text] [Related]  

  • 17. A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
    Xiong Y; Wu X; Mahmud T
    Chembiochem; 2005 May; 6(5):834-7. PubMed ID: 15791687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electron microscopic observations on the ultrastructure of tubercle bacilli after isobutyl piperazine rifamycin treatment].
    Mei GH
    Zhonghua Yi Xue Za Zhi; 1983 Dec; 63(12):734-6. PubMed ID: 6426743
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review).
    Velichka D; Ivana A; Haruaki T; Katsumasa S; Venkata R; Nadadhur G; Donna D; Todor K; Arvind D; Yurii F; Ljudmila Y; Toumanov A; Zvetana Z; Chiaki S
    Recent Pat Antiinfect Drug Discov; 2010 Jan; 5(1):76-90. PubMed ID: 19929844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
    Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
    J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.